Science A groundbreaking pilot study by the University of California, San Francisco (UCSF) investigates psilocybin, a compound from 'magic mushrooms', for the treatment of Parkinson's disease. The results show not only safety of use, but also unexpected, significant improvements in mood, cognition and motor symptoms, paving the way for new therapeutic approaches.